Skip to main content


Page 3 of 34

  1. To assess the impact of long-acting insulin analogues, compared to intermediate acting neutral protamine Hagedron (NPH), on maternal, perinatal and neonatal outcomes.

    Authors: Jijiao Wang, Xiaochen Ji, Ting Liu and Nan Zhao
    Citation: Diabetology & Metabolic Syndrome 2022 14:154
  2. The aim of this systematic review and meta-analysis was to determine the effect of olive leaf extract (OLE) supplementation on cardiovascular-related variables, including lipid, glycemic, inflammatory, liver a...

    Authors: Elham Razmpoosh, Shima Abdollahi, Mahdieh Mousavirad, Cain C. T. Clark and Sepideh Soltani
    Citation: Diabetology & Metabolic Syndrome 2022 14:151
  3. Metabolically healthy obesity (MHO), has been recognized as a transient phenotype with few cardiometabolic diseases; however, little is known regarding the development of hypertension in subjects with an absen...

    Authors: Yue Yuan, Wei Sun and Xiangqing Kong
    Citation: Diabetology & Metabolic Syndrome 2022 14:150
  4. The clustering of metabolic abnormalities may weaken vaccine-induced immunity, but epidemiological data regarding SARS-CoV-2 vaccines are scarce. The present study aimed to examine the cross-sectional associat...

    Authors: Dong Van Hoang, Shohei Yamamoto, Ami Fukunaga, Yosuke Inoue, Tetsuya Mizoue and Norio Ohmagari
    Citation: Diabetology & Metabolic Syndrome 2022 14:149
  5. Diabetes-induced liver injury is a complication of diabetes mellitus of which there are no approved drugs for effective treatment or prevention. This study investigates possible hepatoprotective effect of alph...

    Authors: George J. Dugbartey, Karl K. Alornyo, Ismaila Adams, Stephen Atule, Richard Obeng-Kyeremeh, Daniel Amoah and Samuel Adjei
    Citation: Diabetology & Metabolic Syndrome 2022 14:148
  6. The hypothalamus of the central nervous system is implicated in the development of diabetes due to its glucose-sensing function. Dysregulation of the hypothalamic glucose-sensing neurons leads to abnormal gluc...

    Authors: Edina Pandur, István Szabó, Edina Hormay, Ramóna Pap, Attila Almási, Katalin Sipos, Viktória Farkas and Zoltán Karádi
    Citation: Diabetology & Metabolic Syndrome 2022 14:147
  7. Excess adipose tissue is associated with increased cardiovascular and metabolic risk, but the volume of visceral and subcutaneous adipose tissue poses different metabolic risks. MRI with fat suppression can be...

    Authors: Christine Haugen, Vegard Lysne, Ingfrid Haldorsen, Erling Tjora, Oddrun Anita Gudbrandsen, Jørn Vegard Sagen, Simon N. Dankel and Gunnar Mellgren
    Citation: Diabetology & Metabolic Syndrome 2022 14:146
  8. Measurement of estimated glucose disposal rate (eGDR) has been demonstrated to be an indicator of insulin resistance (IR) and a risk sign for long-term outcomes in those with ischemic heart disease and type 2 ...

    Authors: Chi Liu, Xiaoli Liu, Xiaoteng Ma, Yujing Cheng, Yan Sun, Dai Zhang, Qi Zhao and Yujie Zhou
    Citation: Diabetology & Metabolic Syndrome 2022 14:145
  9. Maternal complications of pregnancy, including hypertensive disorders of pregnancy, gestational diabetes mellitus, intrauterine growth restriction, preterm labour, and placental abruption, are associated with ...

    Authors: Emily Aldridge, Maleesa Pathirana, Melanie Wittwer, Susan Sierp, Shalem Y. Leemaqz, Claire T. Roberts, Gustaaf A. Dekker and Margaret A. Arstall
    Citation: Diabetology & Metabolic Syndrome 2022 14:144
  10. The nutrition transition in developing countries like Iran causes the increasing rise of obesity and abdominal obesity rates. However, it is not yet well proven that environmental modifications like improving ...

    Authors: Fatemeh Gholami, Mahsa Samadi, Neda Soveid and Khadijeh Mirzaei
    Citation: Diabetology & Metabolic Syndrome 2022 14:143
  11. Increased serum carcinoembryonic antigen (CEA) levels are reported to be associated with various metabolic and inflammatory diseases. This study assessed whether high-normal serum CEA is related to diabetic pe...

    Authors: Chun-hua Wang, Chao Yu, Lei Zhuang, Feng Xu, Li-hua Zhao, Xiao-hua Wang, Li-yan Ning, Xiu-lin Zhang, Dong-mei Zhang, Xue-qin Wang and Jian-bin Su
    Citation: Diabetology & Metabolic Syndrome 2022 14:142
  12. This study aimed to evaluate whether soluble vascular cytoadhesive molecule-1 (sVCAM-1), intracellular cytoadhesive molecule-1 (sICAM-1), and endothelial function as assessed by EndoPat outweighed traditional ...

    Authors: Alessandra Saldanha de Mattos Matheus, Maria de Fátima Bevilacqua da Matta, Eliete Leão Silva Clemente, Maria de Lourdes Guimarães Rodrigues, Débora Cristina Torres Valença, Karla Rezende Guerra Drummond and Marília Brito Gomes
    Citation: Diabetology & Metabolic Syndrome 2022 14:141
  13. An interprofessional medication adherence intervention led by pharmacists, combining motivational interviews and feedback with electronic monitor (EM) drug assessment, was offered to all consecutive patients w...

    Authors: Carole Bandiera, Liliane Lam, Isabella Locatelli, Jennifer Dotta-Celio, Dina Duarte, Gregoire Wuerzner, Menno Pruijm, Anne Zanchi and Marie P. Schneider
    Citation: Diabetology & Metabolic Syndrome 2022 14:140
  14. The purpose of this study was to investigate the psychometric properties of the Persian version of Diabetes Health Literacy Scale in type 2 diabetic patients.

    Authors: Mahdi Moshki, Ali Alami, Zohreh Zadehahmad, Mousa Ghelichi-Ghojogh, Mitra Dogonchi and Alireza Jafari
    Citation: Diabetology & Metabolic Syndrome 2022 14:139

    The Correction to this article has been published in Diabetology & Metabolic Syndrome 2022 14:174

  15. Chinese diabetes society has published the new diagnostic criteria for diabetes in China (2020 edition). We aimed to investigate the predictive value of new diabetes-diagnosed criteria for cardiovascular disea...

    Authors: Zixiang Ye, Yanxiang Gao, Enmin Xie, Yike Li, Ziyu Guo, Peizhao Li, Jingyi Ren and Jingang Zheng
    Citation: Diabetology & Metabolic Syndrome 2022 14:138
  16. Several studies have investigated the association of insulin resistance (IR) surrogates and the risk of hypertension. However, it is unclear whether there exist differences between different IR surrogates and ...

    Authors: Wenke Cheng, Fanliang Kong and Siwei Chen
    Citation: Diabetology & Metabolic Syndrome 2022 14:137
  17. Previous studies suggest intestinal dysbiosis is associated with metabolic diseases. However, the causal relationship between them is not fully elucidated. Gut microbiota evaluation of patients with congenital...

    Authors: Renan Magalhães Montenegro Junior, Clarisse Mourão Melo Ponte, Maria Helane Costa Gurgel Castelo, Alessandro Conrado de Oliveira Silveira, Virgínia Oliveira Fernandes, Catarina Brasil D’Alva, Luiz Felipe Valter Oliveira, Angélica Domingues Hristov, Silviane Praciano Bandeira, Grayce Ellen da Cruz Paiva and José Eduardo Levi
    Citation: Diabetology & Metabolic Syndrome 2022 14:136
  18. Salvianolic acid A (SalA) is the main water-soluble component isolated from Salvia miltiorrhiza. This study explored the influences of SalA on intestinal microbiota composition and lipid metabolism in Zucker diab...

    Authors: Xufeng Wang, Xiangjun Sun, Abulikemu Abulizi, Jinyao Xu, Yun He, Qian Chen and Ruicheng Yan
    Citation: Diabetology & Metabolic Syndrome 2022 14:135
  19. There is an increased burden of diabetes globally including in sub-Saharan Africa. The literature shows that glycaemic control among type 2 diabetes patients is poor in most countries in sub-Saharan Africa. Un...

    Authors: Jean-Pierre Fina Lubaki, Olufemi Babatunde Omole and Joel Msafiri Francis
    Citation: Diabetology & Metabolic Syndrome 2022 14:134
  20. Diabetic foot ulcer (DFU) is a common diabetes mellitus (DM) complication. Individuals with DM and a DFU achieved significantly lower scores in cognitive tests than those without a DFU. We investigated whether...

    Authors: Yael Sela, Keren Grinberg, Tali Cukierman-Yaffe and Rachel Natovich
    Citation: Diabetology & Metabolic Syndrome 2022 14:133
  21. We aimed to investigate the joint effect of visit-to-visit variability (VVV) in low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides and glycosylated hemoglo...

    Authors: Panpan He, Xiaoqin Gan, Qimeng Wu, Ziliang Ye, Sisi Yang, Yanjun Zhang, Huan Li, Chun Zhou, Yuanyuan Zhang, Mengyi Liu and Xianhui Qin
    Citation: Diabetology & Metabolic Syndrome 2022 14:132
  22. Ambulatory blood pressure monitoring (ABPM) in patients with diabetes mellitus (DM) and hypertension (HTN) show the dipping patterns, identify masked uncontrolled hypertension (MUCH), and demonstrate the effec...

    Authors: Pop Călin, Manea Viorel, Pruna Luchiana, Cosma Mihaela and Pop Lavinia
    Citation: Diabetology & Metabolic Syndrome 2022 14:130
  23. A main factor contributing to insufficient glycemic control, during basal/bolus insulin therapy, is poor self-management bolus. Insulin bolus administration frequency is strongly associated with glycated hemog...

    Authors: Vanessa Araujo Montanari, Mônica Andrade Lima Gabbay and Sérgio Atala Dib
    Citation: Diabetology & Metabolic Syndrome 2022 14:129
  24. Type 1 diabetes (T1D) and celiac disease (CD) coexist very often. Identification of the human leukocyte antigen (HLA) DQ2/DQ8 can confirm the genetic predisposition to CD. Negative result of this test allows t...

    Authors: Agnieszka Zubkiewicz-Kucharska, Tatiana Jamer, Joanna Chrzanowska, Katarzyna Akutko, Tomasz Pytrus, Andrzej Stawarski and Anna Noczyńska
    Citation: Diabetology & Metabolic Syndrome 2022 14:128
  25. Plasminogen activator inhibitor 1 (PAI-1) also known as serpin E1 or endothelial plasminogen activator inhibitor, is produced from endothelial cells and adipose tissue. PAI-1 inhibits tissue plasminogen activa...

    Authors: Gaber El-Saber Batiha, Hayder M. Al-kuraishy, Thabat J. Al-Maiahy, Ali K. Al-Buhadily, Hebatallah M. Saad, Ali I. Al-Gareeb and Jesus Simal-Gandara
    Citation: Diabetology & Metabolic Syndrome 2022 14:127
  26. Hyperglycemic non-diabetic stroke patients have a worse prognosis than both normoglycemic and diabetic patients. Aim of this study was to assess whether hyperglycemia is an aggravating factor or just an epiphe...

    Authors: Antonio Muscari, Roberta Falcone, Guerino Recinella, Luca Faccioli, Paola Forti, Marco Pastore Trossello, Giovanni M. Puddu, Luca Spinardi and Marco Zoli
    Citation: Diabetology & Metabolic Syndrome 2022 14:126
  27. Interleukin-6 (IL-6) is an inflammation-related cytokine associated with an elevated risk of cardiovascular events. In a previous study, we demonstrated that increased IL-6 was predictive of sub-clinical ather...

    Authors: Márcio Mossmann, Marco Vugman Wainstein, Stéfani Mariani, Guilherme Pinheiro Machado, Gustavo Neves de Araújo, Michael Andrades, Sandro Cadaval Gonçalves and Marcello Casaccia Bertoluci
    Citation: Diabetology & Metabolic Syndrome 2022 14:125
  28. As one of the severe complications of diabetes mellitus, diabetic retinopathy (DR) is the leading cause of blindness in the working age worldwide. Although panretinal photocoagulation (PRP) was standard treatm...

    Authors: Jinglan Li, Xuanlong Li, Mingxing Lei, Wanyue Li, Wenqian Chen, Tianju Ma, Yi Gao, Zi Ye and Zhaohui Li
    Citation: Diabetology & Metabolic Syndrome 2022 14:124
  29. Gaussian graphical models (GGM) are an innovative method for deriving dietary networks which reflect dietary intake patterns and demonstrate how food groups are consuming in relation to each other, independent...

    Authors: Reihaneh Jahanmiri, Kurosh Djafarian, Nasim Janbozorgi, Fatemeh Dehghani-Firouzabadi and Sakineh Shab-Bidar
    Citation: Diabetology & Metabolic Syndrome 2022 14:123
  30. Diabetes-induced chronic hyperglycemia results in the formation and aggregation of advanced glycation end-products (AGEs), which are products of non-enzymatic glycosylation of lipids or proteins. The developme...

    Authors: Mohaddeseh Rezaei, Soghra Rabizadeh, Maryam Mirahmad, Minoo Sadat Hajmiri, Manouchehr Nakhjavani, Mahboobeh Hemmatabadi and Nooshin Shirzad
    Citation: Diabetology & Metabolic Syndrome 2022 14:122
  31. Glucose cotransporter (SGLT) 2 suppression provides potent renal protective effect during diabetic kidney disease (DKD). This work aimed to explore how empagliflozin (EMPA, the selective and strong inhibitor o...

    Authors: Hong Sun, Juan Chen, Yulin Hua, Yuyang Zhang and Zheng Liu
    Citation: Diabetology & Metabolic Syndrome 2022 14:121
  32. Type 2 Diabetes mellitus is one of the most common chronic diseases in the world and has many complications. Due to the importance of using alternative therapies in managing symptoms of this disease, the prese...

    Authors: Shima Nematollahi, Gholam Reza Pishdad, Mehrnoosh Zakerkish, Foroogh Namjoyan, Kambiz Ahmadi Angali and Fatemeh Borazjani
    Citation: Diabetology & Metabolic Syndrome 2022 14:120
  33. Metabolic syndrome (MetS) is a cluster of conditions associated with glucose intolerance, hypertension, abdominal obesity, dyslipidemia, and insulin resistance that increase the risk of cardiovascular diseases...

    Authors: Sanghoo Lee, Seol-A Kim, Jeonghoon Hong, Yejin Kim, Gayeon Hong, SaeYun Baik, Kyeonghwan Choi, Mi-Kyeong Lee and Kyoung-Ryul Lee
    Citation: Diabetology & Metabolic Syndrome 2022 14:119
  34. Obesity and related metabolic disorders are associated with genetic and epigenetic alterations. In this study, we have examined the association between polymorphisms and hypermethylation of the CD36 gene promoter...

    Authors: Maïmouna Touré, Aziz Hichami, Amira Sayed, Muhtadi Suliman, Abdoulaye Samb and Naim Akhtar Khan
    Citation: Diabetology & Metabolic Syndrome 2022 14:117
  35. Peripheral and central hemodynamic indices are modifiable by lifestyle and medical intervention. We aimed to determine the long-term effect of intensive multifactorial treatment on peripheral and central hemod...

    Authors: Lasse Bjerg, Esben Laugesen, Signe Toft Andersen, Jonas Frey Rosborg, Morten Charles, Dorte Vistisen and Daniel R. Witte
    Citation: Diabetology & Metabolic Syndrome 2022 14:116
  36. Metabolic dysfunction and associated systemic inflammation are risk factors for chronic obstructive pulmonary disease (COPD) and COPD is highly prevalent in men. We investigated the impact of metabolic-associa...

    Authors: Tsubasa Tsutsumi, Dan Nakano, Machiko Kawaguchi, Ryuki Hashida, Shinobu Yoshinaga, Hirokazu Takahashi, Keizo Anzai and Takumi Kawaguchi
    Citation: Diabetology & Metabolic Syndrome 2022 14:115
  37. The β-cell function and insulin resistance required by existing methods of classifying type 2 diabetes are not routinely adopted in most medical institutions of developing countries and regions. This study aim...

    Authors: Jing Xie, Xin Zhang, Hua Shao, Shenqi Jing, Tao Shan, Yaxiang Shi, Yong Li, Yun Liu and Naifeng Liu
    Citation: Diabetology & Metabolic Syndrome 2022 14:113
  38. With the pandemic of metabolic diseases, nonalcoholic fatty liver disease (NAFLD) prevalence has dramatically elevated. NAFLD encompasses a spectrum of diseases including simple steatosis and nonalcoholic stea...

    Authors: Juan Pang, Ke Chen, Shen Chen and Xu Chen
    Citation: Diabetology & Metabolic Syndrome 2022 14:112
  39. The principal objective of this study was to gain a better understanding of the mechanisms of type 2 diabetes mellitus (T2DM) patients with fatigue (D-T2DM) through exome and transcriptome sequencing.

    Authors: Bohan Lv, Xiuyan Yang, Tian An, Yanxiang Wu, Zhongchen He, Bowu Li, Yijiao Wang, Fang Tan, Tingye Wang, Jiajian Zhu, Yuanyuan Hu, Xiaokun Liu and Guangjian Jiang
    Citation: Diabetology & Metabolic Syndrome 2022 14:111
  40. This study aimed to determine whether a simultaneous diagnosis of main components of metabolic syndrome (MetS) (hypertension, diabetes mellitus, and dyslipidemia) plays a mediator between income level and stroke.

    Authors: Seungmin Jeong, Sung-il Cho and So Yeon Kong
    Citation: Diabetology & Metabolic Syndrome 2022 14:110
  41. Osteocalcin, a protein secreted mainly by mature osteoblasts, has been shown to be involved in glucose metabolism through various pathways. However, few studies has explored the association between osteocalcin...

    Authors: Jun Liu, Yinghua Wei, Pu Zang, Wei Wang, Zhouqin Feng, Yanyu Yuan, Hui Zhou, Zhen Zhang, Haiyan Lei, Xinyi Yang, Jun Liu, Bin Lu and Jiaqing Shao
    Citation: Diabetology & Metabolic Syndrome 2022 14:109
  42. We aimed to investigate changes of bile acids and resting energy expenditure (REE) in patients with type 2 diabetes mellitus (T2DM) after laparoscopic cholecystectomy (LC) and the role in metabolic homeostasis.

    Authors: Haixin Yin, Weijie Chen, Xiaodong He and Jianping Zeng
    Citation: Diabetology & Metabolic Syndrome 2022 14:108
  43. Coronary Heart Disease (CHD) is the leading cause of death in industrialized countries. There is currently no direct relation between CHD and type 2 diabetes mellitus (T2D), one of the major modifiable risk fa...

    Authors: Salma Ahmadloo, King-Hwa Ling, Ahmad Fazli, Ghazaleh Larijani, Nooshin Ghodsian, Sanaz Mohammadi, Naser Amini, Vahid Hosseinpour Sarmadi and Patimah Ismail
    Citation: Diabetology & Metabolic Syndrome 2022 14:107
  44. TCF7L2 rs7903146 and PNPLA3 rs738409 gene variants confer the strongest risk for type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD), respectively. Pancreatic triacylglycerol content (P...

    Authors: Ákos Nádasdi, Viktor Gál, Tamás Masszi, Attila Patócs, Peter Igaz, Anikó Somogyi and Gábor Firneisz
    Citation: Diabetology & Metabolic Syndrome 2022 14:106
  45. Type 2 Diabetes Mellitus (T2DM) patients are twice as likely to develop dementia. The study’s goal was to evaluate cognitive performance and risk factors for cognitive decline in this population.

    Authors: Ana Cristina Ravazzani de Almeida Faria, Joceline Franco Dall’Agnol, Aline Maciel Gouveia, Clara Inácio de Paiva, Victoria Chechetto Segalla and Cristina Pellegrino Baena
    Citation: Diabetology & Metabolic Syndrome 2022 14:105

New Content Item

The official journal of the Brazilian Diabetes Society.

Annual Journal Metrics